Karthikeyan Ramalingam is a highly accomplished academic and researcher with over 23 years of teaching experience. He currently serves as a Professor at B.S. Abdur Rahman Crescent Institute of Science and Technology, India, and also holds the positions of Dean of Student Affairs and Chief Proctor (Discipline) at the institute. He is also the CEO and Founder of Nano I Technology, a startup company that focuses on nanoemulsion and nanoparticle-based antimicrobial agents for ESKAPE pathogens, biofilm inhibitors, and bioactive venoms compound from marine sources. He has a PhD in Marine Biology from Annamalai University, India, and has held several postdoctoral positions as a Research Scientist at prestigious institutions such as the Naval Medical Research Unit-San Antonio, the University of Texas Health Science Center in San Antonio, Texas, USA and New York University (NYU), USA. Dr. Ramalingam's research expertise includes microbiology, ESKAPE pathogens, infectious diseases, and nanotechnology, with a focus on developing novel therapies for drug-resistant pathogens. He has published over 50+ research articles, and eight funded projects, and holds three patents. He is a member of several professional societies, including the American Society for Microbiology, the New York Academy of Sciences, and the Association of Microbiologists of India.

Select Guide Rating

• 1. Introduction to ESKAPE Pathogens2. Mechanisms of Virulence in ESKAPE Pathogens3. Antibiotic Resistance in ESKAPE Pathogens4. Antimicrobial Compounds to Overcome ESKAPE Pathogens5. Emerging Strategies in the Fight Against Colistin-Resistant ESKAPE Pathogens6. Novel Approaches to Tackle Carbapenem-Resistant ESKAPE Pathogens7. Mobile Genetic Elements and Antibiotic Resistance in ESKAPE Pathogens8. Molecular Basis of Antimicrobial Resistance in Bacteria ESKAPE9. Clinical Management and Diagnostic Methods of ESKAPE Infections10. Host-pathogen Interactions in ESKAPE Infections- Related Infection Models11. The Role of Biofilms in ESKAPE Pathogenesis and Antibiotic Resistance12. Compounds for Antibiofilm Action Against ESKAPE Pathogens13. Infection Control and Prevention Strategies for ESKAPE Pathogens14. Novel Therapeutic Approaches for ESKAPE Pathogens15. Role of Quorum Sensing in ESKAPE Pathogen Pathogenesis16. Interactions between ESKAPE Pathogens and the Host Immune System17. Epidemiology and Surveillance of ESKAPE Pathogens18. Prospects and Challenges in Research and Management of ESKAPE Pathogens